Clinical Trial Update: Assessment of the Role of the Growth Hormone (GH) Onthe Intestinal Triglyceride-rich-lipoproteins (TRL) Metabolism [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing how growth hormone influences intestinal triglyceride-rich lipoprotein metabolism in patients with atherosclerotic cardiovascul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Atherosclerotic Cardiovascular Disease | Phase 3 | Status: UNKNOWN